Ro60-0175
Prijeđi na navigaciju
Prijeđi na pretragu
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| (S)-6-Chloro-5-fluoro-1H-indole-2-propanamine | |||
| Klinički podaci | |||
| Identifikatori | |||
| CAS broj | 169675-09-6 | ||
| ATC kod | ? | ||
| PubChem[1][2] | 5312145 | ||
| Hemijski podaci | |||
| Formula | C11H12ClFN2 | ||
| Mol. masa | 226.677 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
Ro60-0175 je lek koji je razvila kompanija Hoffmann–La Roche. On se primenjuje u naučnim istraživanjima.[3][4] Ro60-0175 je potentan i selektivan agonist 5-HT2B i 5-HT2C serotoninskih receptorskih tipova, sa dobrom selektivnošću u odnosu na srodni 5-HT2A tip, i neznatnim afinitetom za druge receptore.[5][6]
Vidi još[uredi | uredi kod]
Literatura[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Quarta D, Naylor CG, Stolerman IP. The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination. Psychopharmacology (Berlin). 2007 Aug;193(3):391-402. PMID 17473916
- ↑ Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA. The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology. 2008 May;33(6):1402-12. PMID 17653111
- ↑ Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. British Journal of Pharmacology. 1999 Sep;128(1):13-20. DOI:10.1038/sj.bjp.0702751 PMID 10498829
- ↑ Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD. Neuroendocrine evidence that (S)-2-(6-chloro-5-fluoro-indol-1-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist. Journal of Pharmacology and Experimental Therapeutics. 2003 Mar;304(3):1209-16. PMID 12604698
Spoljašnje veze[uredi | uredi kod]
|
Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini). |